Page last updated: 2024-11-06

phentolamine and Brugada Syndrome

phentolamine has been researched along with Brugada Syndrome in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Brugada Syndrome: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MORRIS, LE1
YEIN, CS1
HAID, B1
WHITE, JM1

Other Studies

1 other study available for phentolamine and Brugada Syndrome

ArticleYear
Laboratory and clinical observations on the effect of regitine (C-7337) on cardiac irregularities during cyclopropane anesthesia.
    The Journal of pharmacology and experimental therapeutics, 1952, Volume: 106, Issue:1

    Topics: Anesthesia; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cyclopropanes

1952